Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa
- 31 March 1995
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 89 (3) , 199-207
- https://doi.org/10.1016/0954-6111(95)90248-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- HIV-associated tuberculosis in developing countries: epidemiology and strategies for preventionTubercle and Lung Disease, 1992
- An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infectionTubercle and Lung Disease, 1992
- Supply and use of essential drugs in sub-Saharan Africa: Some issues and possible solutionsSocial Science & Medicine, 1991
- Mycobacterium vaccae immunotherapyThe Lancet, 1991
- Is Africa lost?The Lancet, 1991
- HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDSAIDS, 1991
- Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccaeTubercle, 1990
- Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosisVaccine, 1990
- Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosisTubercle, 1990
- Health services inequalities in NigeriaSocial Science & Medicine, 1988